BAUDAX BIO INC's ticker is BXRX and the CUSIP is 07160F107. A total of 64 filers reported holding BAUDAX BIO INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,320,000 | – | 190,699 | – | 1.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH RUN CAPITAL, LP | 1,009,399 | $2,796,000 | 3.23% |
| Corsair Capital Management | 432,752 | $1,199,000 | 0.43% |
| OBERWEIS ASSET MANAGEMENT INC/ | 133,160 | $369,000 | 0.12% |
| Ikarian Capital, LLC | 100,000 | $277,000 | 0.02% |
| Brandywine Global Investment Management, LLC | 218,452 | $606,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,784 | $38,000 | 0.00% |
| COMMONWEALTH EQUITY SERVICES, LLC | 199,507 | $552,000 | 0.00% |
| JOHNSON INVESTMENT COUNSEL INC | 10,000 | $28,000 | 0.00% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 227,314 | $630,000 | 0.00% |
| NORTHERN TRUST CORP | 56,034 | $155,000 | 0.00% |